Sean M. Salmon was appointed Director of Teleflex Inc. As of November 6, 2026, Teleflex Inc has reported 2 leadership change filings to the SEC under Item 5.02 of Form 8-K, from April 30, 2026 to September 9, 2026, naming 1 appointment (Form 8-K, September 9, 2026).
30 companies changed executives this week.
Companies that just changed executives, and the new executive. Before you unlock: the company, the change and what is inside. After: the executive named with their role, how to reach the company, and a person's email only when we found one.
| John Hancock Comvest Private Income Fund | named a new Chief Financial Officer | |
| Bain Capital Specialty Finance, Inc. | named a new Director | |
| Azora Therapeutics, Inc. (DE) | named a new Director | |
| LASE Corp. | named a new Director | |
| Century Communities, Inc. | named a new Executive Chairman |
Sell to companies like Teleflex Inc? Enter your website and see 10 with a filed reason to buy from you this month. Free.
Opens in a new tab. No signup.
Teleflex Inc reported changes in 2 filings among its directors and officers to the SEC on Form 8-K, Item 5.02, from 2026-04-30 to 2026-09-09. They name 1 person. Every row below is cited to the filing it comes from, and this page adds each new change as Teleflex Inc files it.
Layoffs on record: 1 filing or notice, latest 2026-02-26 (layoff filings and notices).
Also on the record for Teleflex Inc
| Date | Record | Figure | Our page | Source |
|---|---|---|---|---|
| September 8, 2026 | Stake report, Schedule 13G/A, by JANUS HENDERSON GROUP Ltd. | 10.3% of the class | 5%+ stakes | Source |
| August 14, 2026 | Stake report, Schedule 13G/A, by T. Rowe Price Investment Management, Inc. | 7.2% of the class | 5%+ stakes | Source |
| May 15, 2026 | Stake report, Schedule 13G/A, by T. Rowe Price Investment Management, Inc. | 8.7% of the class | 5%+ stakes | Source |
| April 30, 2026 | Stake report, Schedule 13G, by Vanguard Capital Management | 5.25% of the class | 5%+ stakes | Source |
| April 29, 2026 | Stake report, Schedule 13G, by Vanguard Portfolio Management | 5.56% of the class | 5%+ stakes | Source |
| March 27, 2026 | Stake report, Schedule 13G/A, by The Vanguard Group | — | 5%+ stakes | Source |
| February 12, 2026 | Stake report, Schedule 13G/A, by AQR Capital Management, LLC | 4.35% of the class | 5%+ stakes | Source |
| February 11, 2026 | Stake report, Schedule 13G/A, by Morgan Stanley | 4.9% of the class | 5%+ stakes | Source |
| November 14, 2025 | Stake report, Schedule 13G, by AQR Capital Management, LLC | 5.35% of the class | 5%+ stakes | Source |
| November 14, 2025 | Stake report, Schedule 13G/A, by T. Rowe Price Investment Management, Inc. | 10.3% of the class | 5%+ stakes | Source |
| October 17, 2025 | Stake report, Schedule 13G/A, by BlackRock, Inc. | 11.7% of the class | 5%+ stakes | Source |
| August 14, 2025 | Stake report, Schedule 13G/A, by JANUS HENDERSON GROUP PLC | 9.4% of the class | 5%+ stakes | Source |
Selling to them or working with them? See who runs Teleflex Inc now and the warning signs.
Free to see. No signup.
Keep reading
More on Teleflex Inc and the records around it.
Teleflex Inc elsewhere on the record
- 5%+ stake filings Sep 2026
- Layoff notices Feb 2026
- Who owns it
Companies that share a holder
- JANUS HENDERSON GROUP Ltd. also filed stake reports on 104 other companies: SURGERY PARTNERS, INC. (Nov 2026), EYEPOINT, INC. (Sep 2026), ZIFF DAVIS, INC. (Sep 2026)
- T. Rowe Price Investment Management, Inc. also filed stake reports on 167 other companies: CABALETTA BIO INC (Nov 2026), MADISON SQUARE GARDEN SPORTS CORP (Nov 2026), MSG RANGERS CORP (Nov 2026)
- Morgan Stanley also filed stake reports on 182 other companies: MDA Space Ltd. (Nov 2026), RiverNorth/DoubleLine Strategic Opportunity Fund, Inc. (Oct 2026), Arbutus Biopharma Corp (Oct 2026)
Watch Teleflex Inc
Get an email when Teleflex Inc files again: a new raise, a leadership change, a layoff or an IPO filing. One email first to confirm; nothing else until you click it. At most one a day, one click to stop. Free for up to 3 companies.
Want the whole picture on Teleflex Inc?
Example from a real report (our sample on Target): “The Q2 2026 earnings report, published August 19, 2026, showed adjusted EPS of $2.46 against an expected $2.33” Source: CNBC
A Full Report on Teleflex Inc: verified, sourced, every claim cited, ready in a few minutes. See pricing.
What the Full Report on Teleflex Inc covers
The Short Answer
Which Company This Is
What They Do, And How The Money Works
Who Runs It, And How To Reach Them
The Money: Funding, Valuation, Runway
Who Pays Them, And Who They Are Up Against
Warning Bells
Sources
15 cited sources found
Plus the sections for what you are deciding, which you pick after ordering.
A real finished report, first screen. Opens in a new tab.
Not ready to order yet? Keep this snapshot.
Sends this preview to you once; we won't add you to any list
Timeline
| Filed | In / out | Person | Role | Effective | Source |
|---|---|---|---|---|---|
| 2026-09-09 | In | Director | 8-K, 2026-09-09 | ||
| 2026-04-30 | Reported | not named in the filing | 8-K, 2026-04-30 |
Who leads Teleflex Inc, as last reported?
For each role that changed in the filings below, the most recent change reported. A role that did not change in these filings is not listed.
- Director: Sean M. Salmon, appointed (filed 2026-09-09).
New leaders reset buying decisions — get the Full Report on Teleflex Inc: who runs it, how the money works and what to watch, every claim linked to its source.
Get the Full ReportFind people with the same kind of experience as the Director at Teleflex Inc, with the record behind each one.
Find candidates like Director at Teleflex IncEvery change, in the filing's words
Appointed: Sean M. Salmon, Director
On September 8, 2026, the Board of Directors (the "Board") of Teleflex Incorporated (the "Company"), upon the recommendation of the Nominating and Governance Committee of the Board, approved an increase in the size of the Board from eight to nine directors and elected Sean M. Salmon to the Board to fill the vacancy created by the increase.
- In connection with his election to the Board, Mr. Salmon was also appointed to the Growth and Operating Committee of the Board.
- Mr. Salmon, age 61, currently provides business and strategic consulting and advisory services through his consulting firm, Zamboni Holdings, LLC, which he founded in December 2025.
- Prior to that, Mr. Salmon had a 21-year career with Medtronic plc, a global healthcare technology company.
- Prior to joining Medtronic, Mr. Salmon held positions at C.R. Bard, Inc. (now part of Becton Dickinson and Company) and Johnson & Johnson.
- Mr. Salmon is currently a director of Adagio Medical Holdings, Inc. In connection with his service on the Board, Mr. Salmon will receive compensation consistent with the compensation currently provided to all Company non-employee directors, as described on pages 15 to 17 of the Company's proxy statement for its 2026 annual meeting of stockholders, filed with the Securities and Exchange Commission on April 13, 2026.
Reported
On April 30, 2026, Teleflex Incorporated (the "Company") announced the appointment of Jason Weidman as the Company's President and Chief Executive Officer, effective as of June 8, 2026 (the "Start Date"), replacing interim President and Chief Executive Officer Stuart A. Randle at that time.
- The Company's Board of Directors (the "Board") expects to appoint Mr. Weidman as a director effective as of the Start Date.
- Mr. Randle will continue as a member of the Board.
- Mr. Weidman, 51, joins the Company from Medtronic plc, a global healthcare technology company ("Medtronic"), where he held a number of senior leadership roles from 2006 to 2026.
- Most recently, Mr. Weidman held the roles of SVP and President, Coronary & Renal Denervation and SVP and President, Aortic, Peripheral and Venous, pursuant to which he spearheaded strategic product innovations and market development initiatives in coronary and peripheral vascular markets.
- Prior to Medtronic, Mr. Weidman held roles at Thoratec Corporation.
- Mr. Weidman received an MBA in Health Care Management from the Wharton School at the University of Pennsylvania, an MS in Mechanical Engineering with a concentration in Biomechanics from Stanford University and a BSE in Mechanical Engineering from the University of Michigan.
- Offer Letter with Mr. Weidman In connection with Mr. Weidman's appointment as President and Chief Executive Officer, the Company and Mr. Weidman entered into an offer letter, dated April 26, 2026 (the "Offer Letter").
Tools for this story
Each opens in a new tab, filled in for Teleflex Inc. With no account yet, you sign up free and land on the result.
Where this comes from
A public company must file a current report on Form 8-K with the SEC within four business days when a director leaves or is elected, or when its chief executive, chief financial, chief accounting or chief operating officer, or another named executive, departs or is appointed. That disclosure goes under Item 5.02 of the report.
Every change on this page is taken from one of those filings and quoted in the company's own words, with a link to the filing, so it can be checked at the source. Where a filing names the person, the role and the date a change takes effect, they are shown beside the quote. Where it does not, the quote stands on its own. A filing states what changed; it rarely states why, and neither does this page.